BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25016976)

  • 1. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.
    Sarisozen C; Abouzeid AH; Torchilin VP
    Eur J Pharm Biopharm; 2014 Oct; 88(2):539-50. PubMed ID: 25016976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.
    Abouzeid AH; Patel NR; Sarisozen C; Torchilin VP
    Pharm Res; 2014 Aug; 31(8):1938-45. PubMed ID: 24522815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
    Perche F; Patel NR; Torchilin VP
    J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.
    Cho H; Lai TC; Kwon GS
    J Control Release; 2013 Feb; 166(1):1-9. PubMed ID: 23246471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.
    Abouzeid AH; Patel NR; Torchilin VP
    Int J Pharm; 2014 Apr; 464(1-2):178-84. PubMed ID: 24440402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.
    Muddineti OS; Kumari P; Ghosh B; Biswas S
    Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.
    Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP
    Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
    Saxena V; Hussain MD
    J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles.
    Zou W; Sarisozen C; Torchilin VP
    J Drug Target; 2017 Mar; 25(3):225-234. PubMed ID: 27616277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin.
    Abouzeid AH; Patel NR; Rachman IM; Senn S; Torchilin VP
    J Drug Target; 2013 Dec; 21(10):994-1000. PubMed ID: 24098980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
    Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
    Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin-anchored poly(lactide) based micelles to improve anticancer activity of curcumin in hepatic and cervical cancer cell monolayers and 3D spheroids.
    Kumari P; Rompicharla SVK; Muddineti OS; Ghosh B; Biswas S
    Int J Biol Macromol; 2018 Sep; 116():1196-1213. PubMed ID: 29753013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-drug delivery to tumor cells via micellar nanocarriers.
    Katragadda U; Teng Q; Rayaprolu BM; Chandran T; Tan C
    Int J Pharm; 2011 Oct; 419(1-2):281-6. PubMed ID: 21820041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
    Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
    Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
    Gill KK; Kaddoumi A; Nazzal S
    Eur J Pharm Sci; 2012 May; 46(1-2):64-71. PubMed ID: 22369858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer.
    Wang BL; Shen YM; Zhang QW; Li YL; Luo M; Liu Z; Li Y; Qian ZY; Gao X; Shi HS
    Int J Nanomedicine; 2013; 8():3521-31. PubMed ID: 24101869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand: synergistic anticancer effect.
    Musacchio T; Laquintana V; Latrofa A; Trapani G; Torchilin VP
    Mol Pharm; 2009; 6(2):468-79. PubMed ID: 19718800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.